HRGN — Harvard Apparatus Regenerative Technology Balance Sheet
0.000.00%
- $30.41m
- $27.92m
- $0.43m
Annual balance sheet for Harvard Apparatus Regenerative Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.03 | 1.24 | 1.24 | 0.432 | 2.49 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.077 | 0 | — | 0.004 | 0.231 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.68 | 1.59 | 1.59 | 0.783 | 3.23 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.399 | 0.279 | 0.196 | 0.073 | 0.304 |
Other Long Term Assets | |||||
Total Assets | 2.08 | 1.87 | 2.4 | 2.61 | 4.44 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.756 | 4.84 | 1.36 | 0.968 | 1.02 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.951 | 4.89 | 1.41 | 0.968 | 1.22 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.13 | -3.03 | 0.989 | 1.65 | 3.22 |
Total Liabilities & Shareholders' Equity | 2.08 | 1.87 | 2.4 | 2.61 | 4.44 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |